Interventional therapies give patients faster relief and better vision outcomes
Ophthalmology Times: January/February 2026
Cataract surgeons discuss their comprehensive approach to IOL counseling
Daniela Ferrara, MD, PhD, FASRS, FARVO, discusses how data from low- and middle-income countries can strengthen US trials, improve equity, and inform innovation as the field looks toward 2026.
Clear counseling and tailored lens choice reduce postoperative dissatisfaction
A closer look at the science powering next-generation retinal treatments
Proactive strategies enhance comfort, adherence, and long-term glaucoma control
Daniela Ferrara, MD, PhD, FASRS, FARVO, discusses how data from low- and middle-income countries can strengthen US trials, improve equity, and inform innovation as the field looks toward 2026.
Leading cataract surgeons discuss their comprehensive approach to IOL counseling, exploring how they bridge expectation gaps and tailor premium lens strategies to each patient's unique anatomy, goals, and lifestyle.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
2
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
3
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
4
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
5